Dr. Reddy trialing Topical Itraconazole 5% (DFD-04)

Written by on July 15, 2016 in clinical trials, New Rosacea Treatments with 0 Comments

Dr. Reddy has listed a clinical trial to continue to investigate Topical Itraconazole 5% as a treatment for the papules and pustules of rosacea. So we can add DFD-04 to the list of new drugs in development for rosacea.

From Dr. Reddy’s 2015 Investor Day Presentation.

We target underserved segments within large disease areas both in Dermatology and Neurology.

Mid-stage dermatology assets

Rosacea: 16M sufferers, 0.8-1M Underserved Segment.

DFD-04: Phase 1, novel repurposed topical API for treatment of rosacea

Clinical Trial NCT02828241

A Study to Assess the Efficacy, Safety and Tolerability of DFD-04

Sponsor: Dr. Reddy’s Laboratories Limited
Study start date: June 2016
Locations: Germany

From a related listed on clinicaltrials.eu, we can see that DFD-04 is topical Itraconazole 5%.

EudraCT Number: 2015-005486-23


A Placebo controlled study to test DFD-04 Ointment 5% in patients with rosacea over 12-weeks

A Multi-center, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Assess the Efficacy, Safety and Tolerability of DFD-04 (itraconazole) Ointment, 5% in Patients with Inflammatory Lesions of Rosacea Over 12-weeks

Related Articles

About the Author

About the Author: David Pascoe started the Rosacea Support Group in October 1998. .

Follow Rosacea Support

Subscribe via RSS Feed Connect on Pinterest Connect on Google Plus

Leave your comment here


Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.